The content on this site is intended for healthcare professionals only
Dr Elena Sperk speaks to ecancer about the TARGIT-E study which was a prospective, multicentric single arm phase II study based on the protocol of the international TARGIT-A study.
The aim of the TARGIT-E study was to confirm the efficacy of a single dose of intraoperative radiotherapy (IORT) in a well selected group of elderly patients with small breast cancer and absence of risk factors. Dr Sperk explores the study design.
She then discusses the results of the study and explores how these results could impact the future treatment of breast cancer.
Prostate cancer
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Adjuvant radiotherapy has no benefit following radical prostatectomy
The Southeast Asian Breast Cancer Symposium; background, aims and successes
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
